高级检索
    强光亮, 钱坤, 戴天阳, 何华钰. 正反方对话:可手术切除ⅠB~ⅢA期EGFR突变阳性NSCLC术后辅助治疗模式探索[J]. 循证医学, 2024, 24(4): 222-226. DOI: 10.12019/j.issn.1671-5144.202406013
    引用本文: 强光亮, 钱坤, 戴天阳, 何华钰. 正反方对话:可手术切除ⅠB~ⅢA期EGFR突变阳性NSCLC术后辅助治疗模式探索[J]. 循证医学, 2024, 24(4): 222-226. DOI: 10.12019/j.issn.1671-5144.202406013
    shu
    QIANG Guang-liang, QIAN Kun, DAI Tian-yang, HE Hua-yu. Debate of Exploration of Adjuvant Therapy Mode for Postoperative ⅠB~ⅢA EGFR Mutated NSCLC[J]. Journal of Evidence-Based Medicine, 2024, 24(4): 222-226. DOI: 10.12019/j.issn.1671-5144.202406013
    Citation: QIANG Guang-liang, QIAN Kun, DAI Tian-yang, HE Hua-yu. Debate of Exploration of Adjuvant Therapy Mode for Postoperative ⅠB~ⅢA EGFR Mutated NSCLC[J]. Journal of Evidence-Based Medicine, 2024, 24(4): 222-226. DOI: 10.12019/j.issn.1671-5144.202406013
    shu

    正反方对话:可手术切除ⅠB~ⅢA期EGFR突变阳性NSCLC术后辅助治疗模式探索

    Debate of Exploration of Adjuvant Therapy Mode for Postoperative ⅠB~ⅢA EGFR Mutated NSCLC

      摘要
      • HTML全文
      • 参考文献(22)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回